FDAnews
www.fdanews.com/articles/134025-merck-takes-loss-on-drug-issues-low-forecast

Merck Takes Loss on Drug, Issues Low Forecast

February 4, 2011
Merck & Co., the second largest U.S. drugmaker, forecast 2011 earnings that missed analyst estimates and posted a fourth-quarter loss after taking a $1.7 billion charge to write down its experimental blood thinner.
NJ